Healthcare Equipment and Supplies
Company Overview of AccessClosure, Inc.
AccessClosure, Inc., a private medical device company, engages in the design, manufacture, and distribution of access site management products to address complex challenges in cardiovascular and peripheral vascular markets. It offers MynxGrip Vascular Closure Device, a water soluble polyethylene glycol sealant that grips and seals the arteriotomy while expanding and filling the tissue tract, and provides a durable hemostasis; and Bengal Radial Compression Band for transradial procedures. The company sells its products through its direct sales force in the United States; and a network of distributors internationally. AccessClosure, Inc. was founded in 2002 and is based in Mountain View, Calif...
645 Clyde Avenue
Mountain View, CA 94043
Founded in 2002
Key Executives for AccessClosure, Inc.
Vice President of Operations
Executive Vice President of Regulatory & Quality Affairs
Compensation as of Fiscal Year 2013.
AccessClosure, Inc. Key Developments
Federal Court Shuts Down Janzen Patent Infringement Claim Against AccessClosure, Inc
Dec 11 13
AccessClosure Inc. has announced that the U.S. Court of Appeals for the Federal Circuit denied a request by St. Jude Medical Inc. to rehear an appeal on a double patenting ruling concerning its U.S. Patent No. 7,008,439, covering technologies to close holes in arteries. The U.S. Court of Appeals' decision, holding the Janzen 439 patent invalid, supports the original jury verdict on Dec. 21, 2010 in the U.S. District Court for the Western District of Arkansas. The U.S. Court of Appeals will send the case back to the Texarkana District Court on December 16, 2013, when it issues its mandate.
AccessClosure, Inc. Announces Distribution Agreement with Ostial Corporation
Oct 8 13
AccessClosure, Inc. announced an exclusive agreement with Ostial Corporation to distribute the Flash Ostial System Dual Balloon Angioplasty Catheter in the United States. The Flash Ostial System is designed to help overcome the challenges of aorto-ostial stenting and compliments the Mynx(R) Product Family of Vascular Closure Devices to expand AccessClosure's portfolio. AccessClosure will showcase its growing portfolio of devices at booth 314 at the Vascular Interventional Advances 2013 (VIVA) this week in Las Vegas, NV, beginning when the exhibit hall opens at the Wynn Hotel.
AccessClosure, Inc. Launches MynxGrip Vascular Closure Device
Feb 27 12
AccessClosure, Inc. announced the FDA approval and US launch of the MynxGrip Vascular Closure Device (VCD). Built on the proven Mynx platform, the MynxGrip VCD offers an active, extravascular and patient-friendly vascular closure solution. MynxGrip adds the proprietary Grip Technology sealant to the distal end of the original Mynx Sealant. The result is a sealant that actively grips and seals the arteriotomy while expanding and filling the tissue tract, providing a durable hemostasis. The MynxGrip Sealant consists of the same Polyethylene Glycol (PEG) polymer used in the original Mynx Sealant. Grip Technology is a new configuration of PEG that adheres to the contours of the vessel wall, providing active closure of the arteriotomy. The MynxGrip Sealant fully resorbs within 30 days, leaving nothing behind but a healed artery.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|